The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

ABSTRACT:

Unlabelled

The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic apoptotic response. Recent advances in our understanding of apoptotic signaling pathways have enabled methods to identify cancers that are "primed" to undergo apoptosis, and have revealed potential biomarkers that may predict which cancers will undergo apoptosis in response to specific therapies. Complementary efforts have focused on developing novel drugs that directly target antiapoptotic BCL2 family proteins. In this review, we summarize the current knowledge of the role of BCL2 family members in cancer development and response to therapy, focusing on targeted therapeutics, recent progres

SUBMITTER: Hata AN 

PROVIDER: S-EPMC4727530 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature